Literature DB >> 22451653

Siglec-15 protein regulates formation of functional osteoclasts in concert with DNAX-activating protein of 12 kDa (DAP12).

Norihiro Ishida-Kitagawa1, Kunitaro Tanaka, Xilinqiqige Bao, Takanori Kimura, Tadashi Miura, Yoshiki Kitaoka, Kouhei Hayashi, Mizuho Sato, Masahiro Maruoka, Takuya Ogawa, Jun Miyoshi, Tatsuo Takeya.   

Abstract

Osteoclasts are multinucleated giant cells that reside in osseous tissues and resorb bone. Signaling mediated by receptor activator of nuclear factor (NF)-κB (RANK) and its ligand leads to the nuclear factor of activated T cells 2/c1 (NFAT2 or NFATc1) expression, a critical step in the formation of functional osteoclasts. In addition, adaptor proteins harboring immunoreceptor tyrosine-based activation motifs, such as DNAX-activating protein of 12 kDa (DAP12), play essential roles. In this study, we identified the gene encoding the lectin Siglec-15 as NFAT2-inducible, and we found that the protein product links RANK ligand-RANK-NFAT2 and DAP12 signaling in mouse osteoclasts. Both the recognition of sialylated glycans by the Siglec-15 V-set domain and the association with DAP12 through its Lys-272 are essential for its function. When Siglec-15 expression was knocked down, fewer multinucleated cells developed, and those that did were morphologically contracted with disordered actin-ring structures. These changes were accompanied by significantly reduced bone resorption. Siglec-15 formed complexes with Syk through DAP12 in response to vitronectin. Furthermore, chimeric molecules consisting of the extracellular and transmembrane regions of Siglec-15 with a K272A mutation and the cytoplasmic region of DAP12 significantly restored bone resorption in cells with knocked down Siglec-15 expression. Together, these results suggested that the Siglec-15-DAP12-Syk-signaling cascade plays a critical role in functional osteoclast formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22451653      PMCID: PMC3366812          DOI: 10.1074/jbc.M111.324194

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development.

Authors:  Marie-Claude Gingras; Hélène Lapillonne; Judith F Margolin
Journal:  Mol Immunol       Date:  2002-03       Impact factor: 4.407

Review 2.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

3.  Osteoclast differentiation factor modulates cell cycle machinery and causes a delay in s phase progression in RAW264 cells.

Authors:  E Meiyanto; M Hoshijima; T Ogawa; N Ishida; T Takeya
Journal:  Biochem Biophys Res Commun       Date:  2001-03-23       Impact factor: 3.575

4.  Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.

Authors:  J Paloneva; M Kestilä; J Wu; A Salminen; T Böhling; V Ruotsalainen; P Hakola; A B Bakker; J H Phillips; P Pekkarinen; L L Lanier; T Timonen; L Peltonen
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

5.  Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation.

Authors:  Tsuyoshi Akagi; Ken Sasai; Hidesaburo Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

6.  Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.

Authors:  Takako Koga; Masanori Inui; Kazuya Inoue; Sunhwa Kim; Ayako Suematsu; Eiji Kobayashi; Toshio Iwata; Hiroshi Ohnishi; Takashi Matozaki; Tatsuhiko Kodama; Tadatsugu Taniguchi; Hiroshi Takayanagi; Toshiyuki Takai
Journal:  Nature       Date:  2004-04-15       Impact factor: 49.962

7.  The signaling adapter protein DAP12 regulates multinucleation during osteoclast development.

Authors:  Mary Beth Humphrey; Kouetsu Ogasawara; Wei Yao; Steven C Spusta; Michael R Daws; Nancy E Lane; Lewis L Lanier; Mary C Nakamura
Journal:  J Bone Miner Res       Date:  2003-12-16       Impact factor: 6.741

8.  High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype.

Authors:  Roberta Faccio; Wei Zou; Graziana Colaianni; Steven L Teitelbaum; F Patrick Ross
Journal:  J Cell Biochem       Date:  2003-12-01       Impact factor: 4.429

9.  DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.

Authors:  Juha Paloneva; Jami Mandelin; Anna Kiialainen; Tom Bohling; Johannes Prudlo; Panu Hakola; Matti Haltia; Yrjo T Konttinen; Leena Peltonen
Journal:  J Exp Med       Date:  2003-08-18       Impact factor: 14.307

10.  Impaired differentiation of osteoclasts in TREM-2-deficient individuals.

Authors:  Marina Cella; Cecilia Buonsanti; Carey Strader; Takayuki Kondo; Andrea Salmaggi; Marco Colonna
Journal:  J Exp Med       Date:  2003-08-11       Impact factor: 14.307

View more
  20 in total

Review 1.  Siglec-mediated regulation of immune cell function in disease.

Authors:  Matthew S Macauley; Paul R Crocker; James C Paulson
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

2.  Mechanism and function of monoclonal antibodies targeting siglec-15 for therapeutic inhibition of osteoclastic bone resorption.

Authors:  Matthew Stuible; Anna Moraitis; Annie Fortin; Stefan Saragosa; Aida Kalbakji; Mario Filion; Gilles B Tremblay
Journal:  J Biol Chem       Date:  2014-01-20       Impact factor: 5.157

Review 3.  Osteoclast differentiation by RANKL and OPG signaling pathways.

Authors:  Nobuyuki Udagawa; Masanori Koide; Midori Nakamura; Yuko Nakamichi; Teruhito Yamashita; Shunsuke Uehara; Yasuhiro Kobayashi; Yuriko Furuya; Hisataka Yasuda; Chie Fukuda; Eisuke Tsuda
Journal:  J Bone Miner Metab       Date:  2020-10-20       Impact factor: 2.626

Review 4.  Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches.

Authors:  Takashi Angata; Corwin M Nycholat; Matthew S Macauley
Journal:  Trends Pharmacol Sci       Date:  2015-10       Impact factor: 14.819

Review 5.  A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.

Authors:  Mary Beth Humphrey; Mary C Nakamura
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

6.  Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-κB and MAPK signalling.

Authors:  Dinesh Thummuri; V G M Naidu; Pradip Chaudhari
Journal:  J Mol Med (Berl)       Date:  2017-07-04       Impact factor: 4.599

7.  The C-type lectin OCILRP2 costimulates EL4 T cell activation via the DAP12-Raf-MAP kinase pathway.

Authors:  Qiang Lou; Wei Zhang; Guangchao Liu; Yuanfang Ma
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

8.  N-acetylglucosamine suppresses osteoclastogenesis in part through the promotion of O-GlcNAcylation.

Authors:  Tomoharu Takeuchi; Moyuko Nagasaka; Miyuki Shimizu; Mayumi Tamura; Yoichiro Arata
Journal:  Bone Rep       Date:  2016-02-03

9.  Negative feedback loop of bone resorption by NFATc1-dependent induction of Cadm1.

Authors:  Shinya Nakamura; Takuma Koyama; Naohiro Izawa; Seitaro Nomura; Takanori Fujita; Yasunori Omata; Takashi Minami; Morio Matsumoto; Masaya Nakamura; Eriko Fujita-Jimbo; Takashi Momoi; Takeshi Miyamoto; Hiroyuki Aburatani; Sakae Tanaka
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

10.  Impact of docosahexaenoic acid on gene expression during osteoclastogenesis in vitro--a comprehensive analysis.

Authors:  Masako Akiyama; Ken-ichi Nakahama; Ikuo Morita
Journal:  Nutrients       Date:  2013-08-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.